Vantis Investment Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$99.2M |
| 2 |
SLB Ltd
SLB
|
+$14M |
| 3 |
Newell Brands
NWL
|
+$8.9M |
| 4 |
Starbucks
SBUX
|
+$6.98M |
| 5 |
Progressive
PGR
|
+$959K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$11.2M |
| 2 |
JPMorgan Chase
JPM
|
+$9.13M |
| 3 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$5.47M |
| 4 |
Eli Lilly
LLY
|
+$4.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 68.13% |
| 2 | Energy | 7.84% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Financials | 4.39% |
| 5 | Consumer Staples | 4.11% |
Similar funds
Vantis Investment Advisers's Q3 2017 Portfolio in Review
As of Q3 2017, Vantis Investment Advisers held 10 positions worth $189M, up 172% from $69.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Vantis Investment Advisers deployed $100M of net new capital in Q3 2017, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was SLB Ltd: 212,500 shares worth $14.8M.
By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 21% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $9.13M trimmed.
- Vantis Investment Advisers's largest Q3 2017 buy was SLB Ltd: 212,500 shares worth $14.8M.
- Vantis Investment Advisers added most to AbbVie in Q3 2017, an estimated $99.2M increase.
- Vantis Investment Advisers's biggest Q3 2017 reduction was JPMorgan Chase, cutting an estimated $9.13M.
- Vantis Investment Advisers fully exited Goldman Sachs in Q3 2017, selling an estimated $11.2M.
- Vantis Investment Advisers's ten largest holdings make up 100% of its $189M portfolio in Q3 2017.
- Vantis Investment Advisers opened 2 new positions and closed 3 in Q3 2017.
- Vantis Investment Advisers's portfolio value rose 172% quarter-over-quarter to $189M.
Based on Vantis Investment Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.